Nigerian Postgraduate Medical Journal

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 28  |  Issue : 4  |  Page : 259--265

Clinical profile and treatment outcome of laryngeal cancer in a Nigerian Tertiary hospital


Iliyasu Yunusa Shuaibu1, Abdulrazak Ajiya2, Shofoluwe Nurudeen Adebola1, Sunday Adeyemi Adewuyi3, Usman Mohammed Aminu1, Auwal Adamu4 
1 Department of Surgery, Division of Otorhinolaryngology, Faculty of Clinical Sciences, College of Medical Sciences, Ahmadu Bello University/Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
2 Department of Otorhinolaryngology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University/Aminu Kano Teaching Hospital, Kano, Nigeria
3 Department of Radio-Oncology, Ahmadu Bello University/Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
4 Department of Otorhinolaryngology, Head and Neck Surgery, Abubakar Tafawa Balewa University Teaching Hospital/ Abubakar Tafawa Balewa University, Bauchi, Nigeria

Correspondence Address:
Dr. Abdulrazak Ajiya
Department of Otorhinolaryngology, Faculty of Clinical Sciences, College of Health Sciences, Bayero University/Aminu Kano Teaching Hospital, Kano
Nigeria

Background: Laryngeal cancer is one of the most common malignancies of the upper aerodigestive tract worldwide, and its management may sometimes be challenging, especially in developing countries due to late presentation, poverty and limited resources. Aim: This study aims to highlight the clinical profile and treatment outcome of laryngeal cancer in our centre. Patients and Methods: This was a retrospective review of patients who were managed for laryngeal cancer between January 2011 and December 2020. Results: There were 90 (89.1%) males and 11 (10.9%) females, with a male-to-female ratio of 8.2:1. The age ranged from 22 to 82 years, with a mean age of 57.2 ± 12.7 years. Fifty patients (49.5%) presented more than 1 year after the onset of the symptoms. Squamous cell carcinoma (SCCA) was the only histological diagnosis observed in our patients. The laryngeal cancer was transglottic in location in 45 (44.6%) patients, while 50 (49.5%) patients presented with Stage III disease. Twenty-one (20.8%) patients had total laryngectomy. Amongst the patients managed, 17 (17.0%) were still on follow-up. Up to 37 (37.0%) were referred for radiotherapy elsewhere after chemotherapy. Forty-one of the patients (40.0%) died during the course of their management. There was a statistically significant association between having definitive surgical management and survival beyond 5 years (Chi-square test = 8.635, P = 0.003). Conclusion: Majority of the patients presented late with transglottic SCCA. Surgical extirpation of the lesion was associated with better prognosis in our patients.


How to cite this article:
Shuaibu IY, Ajiya A, Adebola SN, Adewuyi SA, Aminu UM, Adamu A. Clinical profile and treatment outcome of laryngeal cancer in a Nigerian Tertiary hospital.Niger Postgrad Med J 2021;28:259-265


How to cite this URL:
Shuaibu IY, Ajiya A, Adebola SN, Adewuyi SA, Aminu UM, Adamu A. Clinical profile and treatment outcome of laryngeal cancer in a Nigerian Tertiary hospital. Niger Postgrad Med J [serial online] 2021 [cited 2022 Jan 27 ];28:259-265
Available from: https://www.npmj.org/article.asp?issn=1117-1936;year=2021;volume=28;issue=4;spage=259;epage=265;aulast=Shuaibu;type=0